Astrana HealthASTH +2.98%87 Days Payable is 13.29 as of Mar. 2026, which is 193% above its 10-year median of 4.53. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Astrana Health ranks worse than 89.8% on this metric.
The historical rank and industry rank for Astrana Health's Days Payable or its related term are showing as below:
ASTH'
s Days Payable Range Over the Past 10 Years
Min: 2.51 Med: 4.53 Max: 20.99
Current: 13.44
During the past 13 years, Astrana Health's highest Days Payable was 20.99. The lowest was 2.51. And the median was 4.53.
ASTH's Days Payable is ranked worse than 89.8% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs ASTH: 13.44
Astrana Health's Days Payable
increased
from Mar. 2025 (10.03) to Mar. 2026 (13.29).
It may suggest that Astrana Healthdelayed paying its suppliers.
Astrana Health Days Payable Related Terms
Astrana Health Days Payable Historical Data
* Premium members only.
The historical data trend for Astrana Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Astrana Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Astrana Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Astrana Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astrana Health (ASTH) has a Days Payable of 13.29 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Astrana Health and its competitors. This is 193% above median its historical median of 4.53. Over the past decade, Astrana Health's Days Payable has ranged from 2.51 to 20.99. According to the industry distribution chart, Astrana Health ranks #546 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 89.8%.
Is Astrana Health's Days Payable too high?
Astrana Health's current Days Payable of 13.29 is 193% above median its 10-year median of 4.53. Over the past 10 years, this metric has ranged from a low of 2.51 to a high of 20.99. The Healthcare Providers & Services industry median Days Payable is 58.08. Astrana Health's value of 13.29 is 77.1% below this industry median. Based on the distribution chart, Astrana Health ranks #546 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Days Payable compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #546 out of 608 companies for Days Payable. This places Astrana Health in the lower half of its industry. The industry median Days Payable is 58.08. Astrana Health's value of 13.29 is 77.1% below this benchmark. Historically, Astrana Health's own Days Payable has ranged from 2.51 to 20.99 over the past decade. While the company's 10-year median is 4.53 vs. the industry median of 58.08, Astrana Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Days Payable of 13.29 is 77.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Days Payable is 13.29, which is 193% above median its own 10-year median of 4.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.48 — trading 47.2% below its estimated fair value. The current Days Payable is 13.29, which is 193% above median its 10-year median of 4.53 and 77.1% below the Healthcare Providers & Services industry median of 58.08. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Astrana Health (ASTH), the current Days Payable is 13.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $43.48 is trading 47.2% below its estimated GF Value™ of $82.34.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
Days Payable: 13.29 (193% above median its 10-year median of 4.53)
GF Value™: $82.34 vs. price of $43.48 (47.2% below fair value)
Industry Position: 77.1% below the Healthcare Providers & Services median (#546 of 608)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for ASTH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
